Resmed Cdi revenue and financials
$31.90Change from previous close: −0.31%Absolute change: −$0.10
In the fiscal year ended June 2026, Resmed Cdi reported revenue of $5.65B (+9.85% year over year). Net income was $1.52B, a net margin of 26.9%.
Fiscal year ending in June. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +9.85%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +8.75%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 26.9%
- FY to Jun 2025: 27.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total assets | 8,966 | 8,784 | 8,503 | 8,308 | 8,174 | — |
| Current assets | 4,325 | 4,064 | 3,819 | 3,626 | 3,506 | — |
| Cash and equivalents | 1,469 | 1,661 | 1,417 | 1,384 | 1,209 | — |
| Receivables | 1,085 | 1,046 | 1,047 | 958 | 991 | — |
| Inventory | 946 | 912 | 922 | 946 | 928 | — |
| Net property, plant and equipment | 735 | 729 | 730 | 726 | 718 | — |
| Goodwill | 2,910 | 3,043 | 3,044 | 3,044 | 3,047 | — |
| Other intangible assets | 453 | 425 | 430 | 447 | 465 | — |
| Current liabilities | 1,395 | 1,351 | 1,248 | 1,256 | 1,019 | — |
| Accounts payable | 309 | 273 | 250 | 267 | 278 | — |
| Long-term debt | 399 | 404 | 404 | 409 | 658 | — |
| Total debt | 826 | 843 | 848 | 846 | 852 | — |
| Total liabilities | 2,381 | 2,292 | 2,182 | 2,187 | 2,207 | — |
| Total equity (incl. minority) | 6,585 | 6,492 | 6,321 | 6,121 | 5,968 | — |
| Retained earnings | 7,255 | 6,959 | 6,647 | 6,342 | 6,081 | — |